INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 224 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70,820 | -27.0% | 86,366 | +38.8% | 0.00% | -60.0% |
| Q4 2022 | $97,034 | -23.6% | 62,201 | -15.5% | 0.01% | +25.0% |
| Q3 2022 | $127,000 | -2.3% | 73,597 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $130,000 | -44.2% | 72,362 | +13.4% | 0.00% | -20.0% |
| Q1 2022 | $233,000 | -29.4% | 63,817 | +0.4% | 0.01% | -28.6% |
| Q4 2021 | $330,000 | -40.9% | 63,584 | -17.2% | 0.01% | -30.0% |
| Q3 2021 | $558,000 | -4.5% | 76,809 | +24.4% | 0.01% | 0.0% |
| Q2 2021 | $584,000 | +4.1% | 61,764 | -3.0% | 0.01% | 0.0% |
| Q1 2021 | $561,000 | -24.4% | 63,673 | -22.7% | 0.01% | -37.5% |
| Q4 2020 | $742,000 | -38.7% | 82,399 | -23.0% | 0.02% | -57.9% |
| Q3 2020 | $1,211,000 | -38.4% | 107,051 | +72.6% | 0.04% | -45.7% |
| Q2 2020 | $1,965,000 | – | 62,020 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |